RIKEN opens iPS cell drug discovery platform development collaboration base” in Keihanna Science City”

The platform is under the RIKEN BioResource Research Center (BRC). It will develop fundamental technology for drug discovery and aim for commercialization, as a bridge between academia and industry with a focus on iPS cell technology.

RIKEN news release, April 9, 2018

Most popular posts: